Digestive Health Supplements Market

Market Insights on the Digestive Health Supplements Market, including sales forecast, demand outlook, and key trends

Digestive Health Supplements Market - By Ingredient Type, Product Type, Distribution Channel, and Region - Forecast to 2023-2033

Category: Food & Beverages Published Date : Jul-23 ID: CVC-53391 Format: PDF Pages: 300

Report Highlights According to a research survey conducted by ChemView Consulting, the Digestive Health Supplements Market was worth US$ 17160 Mn. The market is expected to grow at a CAGR of 6% between the forecast period to reach US$ 30730.9 Mn.



Report Includes

Research Scope/Taxonomy:

  • Market Analysis by Ingredient Type:
    • Probiotics
    • Prebiotics
    • Enzymes
    • Fiber
    • Others
  • Market Analysis by Product Type:
    • Capsules
    • Tablets
    • Powder
    • Liquid
    • Others
  • Market Analysis by Distribution Channel:
    • Pharmacies & Drugstores
    • Supermarkets/Hypermarkets
    • Online Retailers
    • Others
  • Market Analysis by Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa






Analyst Credentials

Key Companies Profiled:

  • BioGaia AB
  • Nestlé S.A.
  • Procter & Gamble Co.
  • Pfizer Inc.
  • Abbott Laboratories
  • Danone S.A.
  • Perrigo Company plc
  • Natures Bounty Co.
  • Douglas Laboratories
  • Church & Dwight Co., Inc.
  • Now Health Group, Inc.
  • Glanbia plc
  • Amway Corporation
  • Bayer AG
  • Sun Pharmaceuticals Industries Ltd.
  • Sanofi S.A.
  • Nutrica N.V.
  • Jarrow Formulas, Inc.
  • Purity Products, Inc.
  • Pharmavite LLC

1.1. Global Market Snapshot

1.2. Key Success Factors

1.3. Strategic Analysis and Recommendations

2.1. Market Taxonomy

2.2. Market Definitions

3.1. Preliminary Investigation & Research Design

3.2. Secondary Research & Primary Research

3.3. Data Analysis & Econometric Modelling

3.4. Expert Data Validation

4.1. Supply-Side Trends

4.2. Demand-Side Trends

5.1. Global Market Value (US$ Mn) Analysis, 2018 – 2033

5.2. Incremental $ Opportunity Index, 2023-2033

5.3. Global Market Volume Analysis, 2018 – 2033

6.1. Regional Level Pricing Analysis and Forecast

6.1.1. Manufacturers Level Pricing

6.1.2. Distributor Level Pricing

6.2. Global Pricing Analysis Benchmark

6.3. Cost Breakdown Analysis

7.1. Cross Analysis of Product Type W.R.T. Ingredient Type

8.1. Regional Supply Vs. Demand Gap Assessment

8.2. Top Producing Countries Analysis

9.1. Macroeconomic Factors

9.2. Forecast Factors

9.3. Market Dynamics

9.3.1. Driver

9.3.2. Restraint

9.3.3. Opportunity

9.4. Supply Chain Analysis

9.4.1. List Raw Material Suppliers

9.4.2. List of Manufacturers

9.4.3. List of Distributors

9.4.4. List of Distribution Channels

9.4.5. Distribution Channels Consumption Analysis

9.4.6. Average Profitability Margin Analysis

9.5. Covid-19 Impact Assessment

9.5.1. Economy/Cluster Projections

9.5.2. Covid-19 Economic Assessment

9.5.3. Impact on Target Market

9.5.4. Recovery Scenario

9.6. Regulatory Framework

9.6.1. Regulations of Key Countries

9.6.2. Potential Impact of Regulations

9.7. Porter’s Five Forces Analysis

9.8. Technology Landscape

10.1. Introduction

10.2. Key Market Trends

10.3. Historical and Current Market (2018-2022) and Future Market Analysis (2023-2033) By Ingredient Type [Value (US$ Mn) and Volume Analysis]

10.3.1. Probiotics

10.3.2. Prebiotics

10.3.3. Enzymes

10.3.4. Fiber

10.3.5. Others

10.4. Market Attractiveness Analysis by Ingredient Type

11.1. Introduction

11.2. Historical and Current Market (2018-2022) and Future Market Analysis (2023-2033) By Product Type [Value (US$ Mn) and Volume Analysis]

11.2.1. Capsules

11.2.2. Tablets

11.2.3. Powder

11.2.4. Liquid

11.2.5. Others

11.3. Market Attractiveness Analysis by Product Type

12.1. Introduction

12.2. Historical and Current Market (2018-2022) and Future Market Analysis (2023-2033) By Distribution Channel [Value (US$ Mn) and Volume Analysis]

12.2.1. Pharmacies & Drugstores

12.2.2. Supermarkets/Hypermarkets

12.2.3. Online Retailers

12.2.4. Others

12.3. Market Attractiveness Analysis by Distribution Channel

13.1. Introduction

13.2. Key Market Trends

13.3. Historical and Current Market (2018-2022) and Future Market Analysis (2023-2033) By Region [Value (US$ Mn) and Volume Analysis]

13.3.1. North America

13.3.2. Latin America

13.3.3. Europe

13.3.4. Asia-Pacific

13.3.5. Middle East

13.3.6. Africa

13.4. Market Attractiveness Analysis by Region

14.1. Introduction

14.2. Key Market Trends

14.3. Historical and Current Market Size (2018-2022) and Future Market Size Analysis (2023-2033) [Value (US$ Mn) and Volume Analysis]

14.3.1. By Country

14.3.1.1. U.S.

14.3.1.2. Canada

14.3.2. By Ingredient Type

14.3.3. By Product Type

14.3.4. By Distribution Channel

14.4. Market Attractiveness Analysis

14.4.1. By Country

14.4.2. By Ingredient Type

14.4.3. By Product Type

14.4.4. By Distribution Channel

15.1. Introduction

15.2. Key Market Trends

15.3. Historical and Current Market Size (2018-2022) and Future Market Size Analysis (2023-2033) [Value (US$ Mn) and Volume Analysis]

15.3.1. By Country

15.3.1.1. Brazil

15.3.1.2. Mexico

15.3.1.3. Rest of Latin America

15.3.2. By Ingredient Type

15.3.3. By Product Type

15.3.4. By Distribution Channel

15.4. Market Attractiveness Analysis

15.4.1. By Country

15.4.2. By Ingredient Type

15.4.3. By Product Type

15.4.4. By Distribution Channel

16.1. Introduction

16.2. Key Market Trends

16.3. Historical and Current Market Size (2018-2022) and Future Market Size Analysis (2023-2033) [Value (US$ Mn) and Volume Analysis]

16.3.1. By Country

16.3.1.1. Germany

16.3.1.2. Italy

16.3.1.3. France

16.3.1.4. UK

16.3.1.5. Spain

16.3.1.6. Netherlands

16.3.1.7. Norway

16.3.1.8. Russia

16.3.1.9. Rest of Europe

16.3.2. By Ingredient Type

16.3.3. By Product Type

16.3.4. By Distribution Channel

16.4. Market Attractiveness Analysis

16.4.1. By Country

16.4.2. By Ingredient Type

16.4.3. By Product Type

16.4.4. By Distribution Channel

17.1. Introduction

17.2. Key Market Trends

17.3. Historical and Current Market Size (2018-2022) and Future Market Size Analysis (2023-2033) [Value (US$ Mn) and Volume Analysis]

17.3.1. By Country

17.3.1.1. China

17.3.1.2. Japan

17.3.1.3. South Korea

17.3.1.4. India

17.3.1.5. Indonesia

17.3.1.6. Thailand

17.3.1.7. Vietnam

17.3.1.8. Australia & New Zealand

17.3.1.9. Rest of Asia-Pacific

17.3.2. By Ingredient Type

17.3.3. By Product Type

17.3.4. By Distribution Channel

17.4. Market Attractiveness Analysis

17.4.1. By Country

17.4.2. By Ingredient Type

17.4.3. By Product Type

17.4.4. By Distribution Channel

18.1. Introduction

18.2. Key Market Trends

18.3. Pricing Analysis

18.4. Historical and Current Market Size (2018-2022) and Future Market Size Analysis (2023-2033) [Value (US$ Mn) and Volume Analysis]

18.4.1. By Country

18.4.1.1. Saudi Arabia

18.4.1.2. Turkey

18.4.1.3. U.A.E.

18.4.1.4. Rest of the Middle East

18.4.2. By Ingredient Type

18.4.3. By Product Type

18.4.4. By Distribution Channel

18.5. Market Attractiveness Analysis

18.5.1. By Country

18.5.2. By Ingredient Type

18.5.3. By Product Type

18.5.4. By Distribution Channel

19.1. Introduction

19.2. Key Market Trends

19.3. Pricing Analysis

19.4. Historical and Current Market Size (2018-2022) and Future Market Size Analysis (2023-2033) [Value (US$ Mn) and Volume Analysis]

19.4.1. By Country

19.4.1.1. South Africa

19.4.1.2. Nigeria

19.4.1.3. Egypt

19.4.1.4. Rest of Africa

19.4.2. By Ingredient Type

19.4.3. By Product Type

19.4.4. By Distribution Channel

19.5. Market Attractiveness Analysis

19.5.1. By Country

19.5.2. By Ingredient Type

19.5.3. By Product Type

19.5.4. By Distribution Channel

20.1. Tier Structure Breakdown

20.2. Market Share Analysis

20.3. Production Capacity Analysis

20.4. Company Footprint Analysis

20.4.1. Product Footprint of Players

20.4.2. Regional Footprint of Players

20.4.3. Channel Footprint of Players

20.5. Brand Preference Analysis

20.6. Competition Dashboard

21.1. BioGaia AB.

21.1.1. Company Overview

21.1.2. Product & Financial Portfolio

21.1.3. Manufacturing Facilities

21.1.4. Recent Developments

21.1.5. SWOT Analysis

21.1.6. Strategy Overview

21.2. Nestlé S.A.

21.3. Procter & Gamble Co.

21.4. Pfizer Inc.

21.5. Abbott Laboratories

21.6. Danone S.A.

21.7. Perrigo Company plc

21.8. Natures Bounty Co.

21.9. Douglas Laboratories

21.10. Church & Dwight Co., Inc.

21.11. Now Health Group, Inc.

21.12. Glanbia plc

21.13. Amway Corporation

21.14. Bayer AG

21.15. Sun Pharmaceuticals Industries Ltd.

21.16. Sanofi S.A.

21.17. Nutrica N.V.

21.18. Jarrow Formulas, Inc.

21.19. Purity Products, Inc.

21.20. Pharmavite LLC